Fischer Medical Ventures Secures CDSCO Import Approval for Spincare, Paving Way for Advanced Wound Care in India

Fischer Medical Ventures Secures CDSCO Import Approval for Spincare, Paving Way for Advanced Wound Care in India​

Fischer Medical Ventures Ltd. has achieved a significant regulatory milestone by securing clearance from India's Central Licensing Authority (CDSCO) to import and distribute the Spincare Portable Wound Care System. This approval positions the company at the forefront of India’s rapidly growing advanced wound care market.

The clearance pertains to the Spincare system, which is manufactured by Nanomedic Technologies Ltd., based in Lod, Israel. The designation granted under Form MD-27 of the Medical Devices Rules, 2017, confirms that Spincare can be introduced into the Indian market for distribution and use.

A First-of-Its-Kind Portable Device​

Spincare is a portable, hand-held medical device designed to apply a breathable, transparent nanofiber film directly onto wounds at the point of care. This innovative capability aims to eliminate the need for traditional dressings in many clinical scenarios.

Cleared as a Class C medical device, Spincare is indicated for use across a variety of skin breaches, including:

• Partial and full thickness wounds
• Superficial and partial thickness burns
• Donor site wounds
• Surgical incisions and post-suture sites
• Skin tears, dermatological lesions, and chronic ulcers

The system is intended for use by healthcare professionals in clinical settings and holds a five-year shelf life.

Market Opportunity and Exclusive Distribution Role​

Fischer Medical Ventures holds the exclusive rights to distribute the Spincare system across India and Southeast Asia, leveraging their partnership with Nanomedic Technologies Ltd. The company is strategically positioned to capture value from these expanding markets.

The potential size of both regions demonstrates a substantial multi-billion dollar opportunity for advanced wound care technology:

Global Validation and Management Outlook​

The company announced that Nanomedic Technologies Ltd. has also submitted its application for U.S. Food and Drug Administration (FDA) approval, a process that is currently underway. This anticipated global validation will further strengthen the product's standing in international markets.

Commenting on this development, Mr. Ravindran Govindan, Chairman & Managing Director of Fischer Medical Ventures Limited, stated: "Receiving CDSCO clearance for Spincare is a transformative moment for Fischer Medical Ventures. This approval opens the door to deploying a genuinely differentiated wound care technology across Indian hospitals and burn centers. We see substantial whitespace in this market and are moving quickly to establish our commercial footprint."

The Spincare Portable Wound Care System uses proprietary electrospinning technology to create a nano-fiber protective layer on wounds in real time, which aids healing while mitigating infection risk.

FISCHER Stock Price Movement​

Shares of Fischer Medical Ventures Limited are edging higher as of 3:29 PM, currently trading at ₹39.32 after a significant gain of 9.96%. The stock has seen strong intraday movement, with the share price fluctuating between a low of ₹35.36 and a daily high of ₹39.33.